Number of times cited according to CrossRef:

Louise Morgan, MDMA-assisted psychotherapy for people diagnosed with treatment-resistant PTSD: what it is and what it isn’t, Annals of General Psychiatry, 10.1186/s12991-020-00283-6, 19, 1,

Jessica Paige Mead, Andrew Charles Parrott, Mephedrone and MDMA: a comparative review, Brain Research, 10.1016/j.brainres.2020.146740, (146740),

Tingying Chi, Jessica A. Gold, A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses, Journal of the Neurological Sciences, 10.1016/j.jns.2020.116715, (116715),

Jean-Christophe Cassel, The role of serotonin in learning and memory: a rich pallet of experimental studies, Handbook of the Behavioral Neurobiology of Serotonin, 10.1016/B978-0-444-64125-0.00032-3, (549-570),

Sean B. Dolan, Matthew W. Johnson, The drug purity discounting task: Ecstasy use likelihood is reduced by probabilistic impurity according to harmfulness of adulterants, Drug and Alcohol Dependence, 10.1016/j.drugalcdep.2019.107772, (107772),

Catharine Montgomery, Carl A. Roberts, Cognitive consequences of 3,4-methylenedioxymethamphetamine use, Cognition and Addiction, 10.1016/B978-0-12-815298-0.00012-5, (165-177),

Ian A. Scott, Russ J. Scott, Pill testing at music festivals: is it evidence‐based harm reduction?, Internal Medicine Journal, 10.1111/imj.14742, 50, 4, (395-402),

Sally Meikle, Olivia Carter, Gillinder Bedi, Individual differences in distress, impulsivity, and motives for use as predictors of problematic ecstasy use, Addictive Behaviors, 10.1016/j.addbeh.2020.106397, (106397),

Ansgar Rougemont-Bücking, Die Rolle von psychoaktiven Substanzen bei Lern- und Anpassungsprozessen, Handbuch Psychoaktive Substanzen, 10.1007/978-3-642-55214-4_62-2, (1-16),

Ji Hyun Lee, Ok Rim Park, Suresh Mandava, Jemin Kim, Jaun Koo, Jongkook Lee, Hoil Kang, Identification of a new M-ALPHA analog and MDMA in an illegal health product, Forensic Science International, 10.1016/j.forsciint.2020.110332, (110332),

Jan van Amsterdam, Ed Pennings, Wim van den Brink, Fatal and non-fatal health incidents related to recreational ecstasy use, Journal of Psychopharmacology, 10.1177/0269881119897559, (026988111989755),

Alon Richter, Anat Sason, Miriam Adelson, Omri Frish, Einat Peles, Cognitive state, substance use patterns and outcome after discharge from Kfar Izun, a unique rehabilitation facility, Journal of Addictive Diseases, 10.1080/10550887.2020.1773730, (1-13),

Sami Ben Hamida, Lucas Lecourtier, Michaël Loureiro, Brigitte Cosquer, Antoine Tracqui, Valérie Simmoneaux, Astrid Nehlig, Byron C. Jones, Anne Pereira de Vasconcelos, Jean‐Christophe Cassel, Ventral striatum regulates behavioral response to ethanol and MDMA combination, Addiction Biology, 10.1111/adb.12938, 0, 0,

Jan van Amsterdam, Johannes G. Ramaekers, Ton Nabben, Wim van den Brink, Use characteristics and harm potential of ecstasy in The Netherlands, Drugs: Education, Prevention and Policy, 10.1080/09687637.2020.1818692, (1-11),

Maria A Aguilar, Maria P. García-Pardo, Andrew C Parrott, Of mice and men on MDMA: a translational comparison of the neuropsychobiological effects of 3,4-methylenedioxymethamphetamine (‘Ecstasy’), Brain Research, 10.1016/j.brainres.2019.146556, (146556),

James J. Mahoney, Kirk R. Bryant, Marc W. Haut, Substance Use Disorders: Cognitive Sequelae, Behavioral Manifestations, Neuroimaging Correlates, and Novel Interventions, Handbook of Medical Neuropsychology, 10.1007/978-3-030-14895-9, (697-728),

Anees Bahji, Ashleigh Forsyth, Dianne Groll, Emily R. Hawken, Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 10.1016/j.pnpbp.2019.109735, (109735),

Daniel W. Curry, Laís F. Berro, Andie R. Belkoff, Agnieszka Sulima, Kenner C. Rice, Leonard L. Howell, Sensitization to the prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA), Neuropharmacology, 10.1016/j.neuropharm.2019.03.017,

Marta Barenys, Ingrid Reverte, Stefan Masjosthusmann, Jesús Gómez-Catalán, Ellen Fritsche, Developmental neurotoxicity of MDMA. A systematic literature review summarized in a putative adverse outcome pathway, NeuroToxicology, 10.1016/j.neuro.2019.12.007,

Joseph J. Palamar, Patricia Acosta, Charles M. Cleland, The influence of viewing a headline about ecstasy/Molly adulteration on future intentions to use, Journal of Substance Use, 10.1080/14659891.2019.1664660, (1-6),

Stefania Schiavone, Margherita Neri, Angela Maffione, Paolo Frisoni, Maria Morgese, Luigia Trabace, Emanuela Turillazzi, Increased iNOS and Nitrosative Stress in Dopaminergic Neurons of MDMA-Exposed Rats, International Journal of Molecular Sciences, 10.3390/ijms20051242, 20, 5, (1242),

Elizabeth G. Pitts, Elizabeth T. Barfield, Ellen P. Woon, Shannon L. Gourley, Action-Outcome Expectancies Require Orbitofrontal Neurotrophin Systems in Naïve and Cocaine-Exposed Mice, Neurotherapeutics, 10.1007/s13311-019-00752-1,

Joseph J. Palamar, Monica J. Barratt, Prevalence of reagent test‐kit use and perceptions of purity among ecstasy users in an electronic dance music scene in New York City, Drug and Alcohol Review, 10.1111/dar.12882, 38, 1, (42-49),

Matteo Marti, Margherita Neri, Sabrine Bilel, Marco Di Paolo, Raffaele La Russa, Andrea Ossato, Emanuela Turillazzi, MDMA alone affects sensorimotor and prepulse inhibition responses in mice and rats: tips in the debate on potential MDMA unsafety in human activity, Forensic Toxicology, 10.1007/s11419-018-0444-7, 37, 1, (132-144),

Giulia Costa, Marcello Serra, Nicholas Pintori, Maria Antonietta Casu, Mary Tresa Zanda, Daniela Murtas, Maria Antonietta De Luca, Nicola Simola, Liana Fattore, The novel psychoactive substance methoxetamine induces persistent behavioral abnormalities and neurotoxicity in rats, Neuropharmacology, 10.1016/j.neuropharm.2018.10.031,

Carl A. Roberts, Boris B. Quednow, Catharine Montgomery, Andrew C. Parrott, MDMA and brain activity during neurocognitive performance: An overview of neuroimaging studies with abstinent ‘Ecstasy’ users, Neuroscience & Biobehavioral Reviews, 10.1016/j.neubiorev.2017.07.015, 84, (470-482),

Sascha B. Thal, Miriam J. J. Lommen, Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder, Journal of Contemporary Psychotherapy, 10.1007/s10879-017-9379-2, 48, 2, (99-108),

Daniel W. Curry, Matthew B. Young, Andrew N. Tran, Georges E. Daoud, Leonard L. Howell, Separating the agony from ecstasy: R (–)-3,4-methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in mice, Neuropharmacology, 10.1016/j.neuropharm.2017.10.003, 128, (196-206),

Toby Boote, Is the recreational use of 3,4-methylenedioxy-methamphetamine safe?, Medico-Legal Journal, 10.1177/0025817217747203, 86, 2, (94-99),

Ansgar Rougemont-Bücking, Die Rolle von psychoaktiven Substanzen bei Lern- und Anpassungsprozessen, Handbuch Psychoaktive Substanzen, 10.1007/978-3-642-55125-3, (437-451),

Susan Schenk, David Newcombe, Methylenedioxymethamphetamine (MDMA) in Psychiatry, Journal of Clinical Psychopharmacology, 10.1097/JCP.0000000000000962, 38, 6, (632-638),

Giulia Costa, Micaela Morelli, Nicola Simola, Repeated Administration of 3,4-Methylenedioxymethamphetamine (MDMA) Elevates the Levels of Neuronal Nitric Oxide Synthase in the Nigrostriatal System: Possible Relevance to Neurotoxicity, Neurotoxicity Research, 10.1007/s12640-018-9892-4, 34, 4, (763-768),

Laura E. Kunst, Winifred A. Gebhardt, Prevalence and Psychosocial Correlates of Party-Drug Use and Associated Problems among University Students in the Netherlands, Substance Use & Misuse, 10.1080/10826084.2018.1455700, 53, 12, (2077-2088),

Andrew Parrott, Mood Fluctuation and Psychobiological Instability: The Same Core Functions Are Disrupted by Novel Psychoactive Substances and Established Recreational Drugs, Brain Sciences, 10.3390/brainsci8030043, 8, 3, (43),

Elizabeth G. Pitts, Daniel W. Curry, Karly N. Hampshire, Matthew B. Young, Leonard L. Howell, (±)-MDMA and its enantiomers: potential therapeutic advantages of R(−)-MDMA, Psychopharmacology, 10.1007/s00213-017-4812-5, 235, 2, (377-392),

Cristina Cadoni, Augusta Pisanu, Nicola Simola, Lucia Frau, Pier Francesca Porceddu, Silvia Corongiu, Christian Dessì, Annesha Sil, Antonio Plumitallo, Jadwiga Wardas, Gaetano Di Chiara, Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence, Neuropharmacology, 10.1016/j.neuropharm.2017.06.008, 123, (385-394),

Andrew C. Parrott, Amie C. Hayley, Luke A. Downey, Recreational stimulants, herbal, and spice cannabis: The core psychobiological processes that underlie their damaging effects, Human Psychopharmacology: Clinical and Experimental, 10.1002/hup.2594, 32, 3,

A. Porcu, M.P. Castelli, Cannabis and the Use of Amphetamine-Like Substances, Handbook of Cannabis and Related Pathologies, 10.1016/B978-0-12-800756-3.00066-1, (e101-e110),

Joseph J. Palamar, Pia M. Mauro, Benjamin H. Han, Silvia S. Martins, Shifting characteristics of ecstasy users ages 12–34 in the United States, 2007–2014, Drug and Alcohol Dependence, 10.1016/j.drugalcdep.2017.09.011, 181, (20-24),

Michael D. Wunderli, Matthias Vonmoos, Marina Fürst, Katrin Schädelin, Thomas Kraemer, Markus R. Baumgartner, Erich Seifritz, Boris B. Quednow, Discrete memory impairments in largely pure chronic users of MDMA, European Neuropsychopharmacology, 10.1016/j.euroneuro.2017.08.425, 27, 10, (987-999),

Patrick Vizeli, Matthias E Liechti, Safety pharmacology of acute MDMA administration in healthy subjects, Journal of Psychopharmacology, 10.1177/0269881117691569, 31, 5, (576-588),

Susan Schenk, Dane Aronsen, Contribution of Impulsivity and Serotonin Receptor Neuroadaptations to the Development of an MDMA (‘Ecstasy’) Substance Use Disorder, Non-medical and illicit use of psychoactive drugs, 10.1007/7854_2015_421, (17-32),

Andrew C Parrott, Luke A Downey, Carl A Roberts, Cathy Montgomery, Raimondo Bruno, Helen C Fox, Recreational 3,4-methylenedioxymethamphetamine or ‘ecstasy’: Current perspective and future research prospects, Journal of Psychopharmacology, 10.1177/0269881117711922, 31, 8, (959-966),

Marit Edland-Gryt, Sveinung Sandberg, Willy Pedersen, From ecstasy to MDMA: Recreational drug use, symbolic boundaries, and drug trends, International Journal of Drug Policy, 10.1016/j.drugpo.2017.07.030, 50, (1-8),

C. A. Roberts, A. Jones, C. Montgomery, Meta-analysis of executive functioning in ecstasy/polydrug users, Psychological Medicine, 10.1017/S0033291716000258, 46, 8, (1581-1596),

Ansgar Rougemont-Bücking, Die Rolle von psychoaktiven Substanzen bei Lern- und Anpassungsprozessen, Handbuch Psychoaktive Substanzen, 10.1007/978-3-642-55214-4, (1-19),

Thomas S. Ray, Constructing the ecstasy of MDMA from its component mental organs: Proposing the primer/probe method, Medical Hypotheses, 10.1016/j.mehy.2015.12.018, 87, (48-60),

Andrew C. Parrott, Oxytocin, cortisol and 3,4-methylenedioxymethamphetamine, Behavioural Pharmacology, 10.1097/FBP.0000000000000262, 27, 8, (649-658),

Susan Schenk, Jason Foote, Dane Aronsen, Natasha Bukholt, Quenten Highgate, Ross Van de Wetering, Jeremy Webster, Serotonin antagonists fail to alter MDMA self-administration in rats, Pharmacology Biochemistry and Behavior, 10.1016/j.pbb.2016.06.002, 148, (38-45),

F. Mueller, C. Lenz, M. Steiner, P.C. Dolder, M. Walter, U.E. Lang, M.E. Liechti, S. Borgwardt, Neuroimaging in moderate MDMA use: A systematic review, Neuroscience & Biobehavioral Reviews, 10.1016/j.neubiorev.2015.12.010, 62, (21-34),

Luisa Ponzoni, Braida Daniela, Mariaelvina Sala, Abuse potential of methylenedioxymethamphetamine (MDMA) and its derivatives in zebrafish: role of serotonin 5HT2-type receptors, Psychopharmacology, 10.1007/s00213-016-4352-4, 233, 15-16, (3031-3039),

Jui-Hu Shih, Kuo-Hsing Ma, Chien-Fu F. Chen, Cheng-Yi Cheng, Li-Heng Pao, Shao-Ju Weng, Yuahn-Sieh Huang, Chyng-Yann Shiue, Ming-Kung Yeh, I-Hsun Li, Evaluation of brain SERT occupancy by resveratrol against MDMA-induced neurobiological and behavioral changes in rats: A 4-[ 18 F]-ADAM/small-animal PET study, European Neuropsychopharmacology, 10.1016/j.euroneuro.2015.11.001, 26, 1, (92-104),

Joseph J. Palamar, Alberto Salomone, Marco Vincenti, Charles M. Cleland, Detection of “bath salts” and other novel psychoactive substances in hair samples of ecstasy/MDMA/“Molly” users, Drug and Alcohol Dependence, 10.1016/j.drugalcdep.2016.02.001, 161, (200-205),

Armin Claus, Manfred Gerlach, Rudolf Stohler, Gerhard Wiesbeck, Substanzbezogene Störungen, Neuro-/Psychopharmaka im Kindes- und Jugendalter, 10.1007/978-3-662-48624-5, (575-597),

Christian Montag, Benjamin Becker, Recreational Use of Ecstasy (MDMA) and Hippocampal Memory, Neuropathology of Drug Addictions and Substance Misuse, 10.1016/B978-0-12-800212-4.00044-3, (473-483),

Christopher M. Plummer, Thomas W. Breadon, James R. Pearson, Oliver A.H. Jones, The synthesis and characterisation of MDMA derived from a catalytic oxidation of material isolated from black pepper reveals potential route specific impurities, Science & Justice, 10.1016/j.scijus.2016.01.003, 56, 3, (223-230),

Yosta Vegting, Liesbeth Reneman, Jan Booij, The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies, Psychopharmacology, 10.1007/s00213-016-4396-5, 233, 19-20, (3473-3501),

Kuo-Hsing Ma, Tsung-Ta Liu, Shao-Ju Weng, Chien-Fu F. Chen, Yuahn-Sieh Huang, Sheau-Huei Chueh, Mei-Hsiu Liao, Kang-Wei Chang, Chi-Chang Sung, Te-Hung Hsu, Wen-Sheng Huang, Cheng-Yi Cheng, Effects of dextromethorphan on MDMA-induced serotonergic aberration in the brains of non-human primates using [123I]-ADAM/SPECT, Scientific Reports, 10.1038/srep38695, 6, 1,

Concepción Roger-Sánchez, María P. García-Pardo, Marta Rodríguez-Arias, Jose Miñarro, María A. Aguilar, Neurochemical substrates of the rewarding effects of MDMA, Behavioural Pharmacology, 10.1097/FBP.0000000000000210, 27, (116-132),

Ashley N. Linden-Carmichael, Amy L. Stamates, Brynn E. Sheehan, Cathy Lau-Barraco, Molly users versus nonusers in a sample of college alcohol drinkers: Differences in substance-related harms and sensation seeking, Substance Abuse, 10.1080/08897077.2015.1137536, 37, 3, (474-479),

Nicole May, Rizwana Roomaney, A qualitative study into the protective factors of non-MDMA users who attend trance parties in South Africa, Journal of Substance Use, 10.3109/14659891.2015.1045046, 21, 4, (429-434),

Eugene A Kiyatkin, Suelynn Ren, Ken T Wakabayashi, Michael H Baumann, Yavin Shaham, Clinically Relevant Pharmacological Strategies That Reverse MDMA-Induced Brain Hyperthermia Potentiated by Social Interaction, Neuropsychopharmacology, 10.1038/npp.2015.182, 41, 2, (549-559),

Alexandra Patin, René Hurlemann, Social Cognition, Cognitive Enhancement, 10.1007/978-3-319-16522-6_10, (271-303),

Novel psychoactive substances: second and third international conferences, Human Psychopharmacology: Clinical and Experimental, 10.1002/hup.2501, 30, 4, (209-212),

Luke A. Downey, Helen Sands, Lewis Jones, Angela Clow, Phil Evans, Tobias Stalder, Andrew C. Parrott, Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits, Human Psychopharmacology: Clinical and Experimental, 10.1002/hup.2474, 30, 3, (199-207),

Andrew C. Parrott, Why all stimulant drugs are damaging to recreational users: an empirical overview and psychobiological explanation, Human Psychopharmacology: Clinical and Experimental, 10.1002/hup.2468, 30, 4, (213-224),

Lynn T. Singer, Derek G. Moore, Meeyoung O. Min, Julia Goodwin, John J. D. Turner, Sarah Fulton, Andrew C. Parrott, Developmental outcomes of 3,4‐methylenedioxymethamphetamine (ecstasy)‐exposed infants in the UK, Human Psychopharmacology: Clinical and Experimental, 10.1002/hup.2459, 30, 4, (290-294),

Aimee L. May, Andrew C. Parrott, Greater sexual risk‐taking in female and male recreational MDMA/ecstasy users compared with alcohol drinkers: a questionnaire study, Human Psychopharmacology: Clinical and Experimental, 10.1002/hup.2432, 30, 4, (272-275),

Carla Letizia Busceti, Paola Di Pietro, Barbara Riozzi, Anna Traficante, Francesca Biagioni, Robert Nisticò, Francesco Fornai, Giuseppe Battaglia, Ferdinando Nicoletti, Valeria Bruno, 5-HT2C serotonin receptor blockade prevents tau protein hyperphosphorylation and corrects the defect in hippocampal synaptic plasticity caused by a combination of environmental stressors in mice, Pharmacological Research, 10.1016/j.phrs.2015.06.017, 99, (258-268),

Timothy Amoroso, The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder, Journal of Psychoactive Drugs, 10.1080/02791072.2015.1094156, 47, 5, (337-344),

Jenny Bearn, Matthew O'Brien, “Addicted to Euphoria”, The Neuropsychiatric Complications of Stimulant Abuse, 10.1016/bs.irn.2015.02.005, (205-233),

Marta Rodríguez-Arias, Sonia Vaccaro, M. Carmen Arenas, María A. Aguilar, José Miñarro, The novelty-seeking phenotype modulates the long-lasting effects of adolescent MDMA exposure, Physiology & Behavior, 10.1016/j.physbeh.2015.01.023, 141, (190-198),

Erika M. Caramillo, Kanza M. Khan, Adam D. Collier, David J. Echevarria, Modeling PTSD in the zebrafish: Are we there yet?, Behavioural Brain Research, 10.1016/j.bbr.2014.05.005, 276, (151-160),

Michael G. Vaughn, Christopher P. Salas-Wright, Matt DeLisi, Brian E. Perron, David Cordova, Crime and Violence among MDMA Users in the United States, AIMS Public Health, 10.3934/publichealth.2015.1.64, 2, 1, (64-73),

Maria C. Blanco-Gandía, Ana Mateos-García, Maria P. García-Pardo, Sandra Montagud-Romero, Marta Rodríguez-Arias, José Miñarro, María A. Aguilar, Effect of drugs of abuse on social behaviour, Behavioural Pharmacology, 10.1097/FBP.0000000000000162, 26, 6, (541-570),

Sunjeev K Kamboj, Emma J Kilford, Stephanie Minchin, Abigail Moss, Will Lawn, Ravi K Das, Caroline J Falconer, Paul Gilbert, H Valerie Curran, Tom P Freeman, Recreational 3,4-methylenedioxy-N-methylamphetamine (MDMA) or ‘ecstasy’ and self-focused compassion: Preliminary steps in the development of a therapeutic psychopharmacology of contemplative practices, Journal of Psychopharmacology, 10.1177/0269881115587143, 29, 9, (961-970),

Daniel Wagner, Simon Tkotz, Philip Koester, Benjamin Becker, Euphrosyne Gouzoulis-Mayfrank, Joerg Daumann, Learning, Memory, and Executive Function in New MDMA Users: A 2-Year Follow-Up Study, Frontiers in Neuroscience, 10.3389/fnins.2015.00445, 9,

Samanta Yubero-Lahoz, K. P. C. Kuypers, J. G. Ramaekers, Klaus Langohr, Magí Farré, Rafael de la Torre, Changes in serotonin transporter (5-HTT) gene expression in peripheral blood cells after MDMA intake, Psychopharmacology, 10.1007/s00213-014-3827-4, 232, 11, (1921-1929),

Andrew C. Parrott, Derek G. Moore, John J.D. Turner, Julia Goodwin, Meeyoung O. Min, Lynn T. Singer, MDMA and heightened cortisol: a neurohormonal perspective on the pregnancy outcomes of mothers used ‘Ecstasy’ during pregnancy, Human Psychopharmacology: Clinical and Experimental, 10.1002/hup.2342, 29, 1, (1-7),

Brian S. Fulton, References, Drug Discovery for the Treatment of Addiction, 10.1002/9781118943670, (290-333),

Jane Carlisle Maxwell, Psychoactive substances—Some new, some old: A scan of the situation in the U.S., Drug and Alcohol Dependence, 10.1016/j.drugalcdep.2013.09.011, 134, (71-77),

Claire White, Mark Edwards, John Brown, Jason Bell, The impact of recreational MDMA ‘ecstasy’ use on global form processing, Journal of Psychopharmacology, 10.1177/0269881114546709, 28, 11, (1018-1029),

Andrew C. Parrott, The Potential Dangers of Using MDMA for Psychotherapy, Journal of Psychoactive Drugs, 10.1080/02791072.2014.873690, 46, 1, (37-43),

Sherrel G. Howard, Amphetamine and Amphetamine Analogs, Drugs of Abuse, 10.1002/9781118850046.ch3, (33-63),

V. Ferraz-de-Paula, A. Ribeiro, J. Souza-Queiroz, M. L. Pinheiro, J. F. Vecina, D. P. M. Souza, W. M. Quinteiro-Filho, R. L. M. Moreau, M. L. S. Queiroz, J. Palermo-Neto, 3,4-Methylenedioxymethamphetamine (MDMA – Ecstasy) Decreases Neutrophil Activity Through the Glucocorticoid Pathway and Impairs Host Resistance to Listeria Monocytogenes Infection in Mice, Journal of Neuroimmune Pharmacology, 10.1007/s11481-014-9562-0, 9, 5, (690-702),

Lise Aagaard, Central Nervous System Stimulants and Drugs that Suppress Appetite, A worldwide yearly survey of new data in adverse drug reactions, 10.1016/B978-0-444-63407-8.00001-0, (1-9),

Elodie Saussereau, Michel Guerbet, Jean-Pierre Anger, Jean-Pierre Goullé, Memory Impairment after Drug-Facilitated Crimes, Toxicological Aspects of Drug-Facilitated Crimes, 10.1016/B978-0-12-416748-3.00005-0, (121-138),

Sarah J. Steinhardt, Thea R. Moore, Sean S. Casella, Have you seen Molly? A review of Molly in primary literature, Mental Health Clinician, 10.9740/mhc.n207181, 4, 5, (231-235),

Claire White, John Brown, Mark Edwards, Alterations to global but not local motion processing in long-term ecstasy (MDMA) users, Psychopharmacology, 10.1007/s00213-014-3431-7, 231, 13, (2611-2622),

A.C. Parrott, H.R. Sands, L. Jones, A. Clow, P. Evans, L.A. Downey, T. Stalder, Increased cortisol levels in hair of recent Ecstasy/MDMA users, European Neuropsychopharmacology, 10.1016/j.euroneuro.2013.11.006, 24, 3, (369-374),

Andrew C Parrott, Lucy Young, Saturday night fever in ecstasy/MDMA dance clubbers: Heightened body temperature and associated psychobiological changes, Temperature, 10.4161/23328940.2014.977182, 1, 3, (214-219),

References, The Role of 5-HT Systems on Memory and Dysfunctional Memory, 10.1016/B978-0-12-800836-2.00022-2, (67-84),

Andrew C. Parrott, MDMA is certainly damaging after 25 years of empirical research: a reply and refutation of Doblin et al. (2014), Human Psychopharmacology: Clinical and Experimental, 10.1002/hup.2390, 29, 2, (109-119),

Rick Doblin, George Greer, Julie Holland, Lisa Jerome, Michael C. Mithoefer, Ben Sessa, A reconsideration and response to Parrott AC (2013) “Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research”, Human Psychopharmacology: Clinical and Experimental, 10.1002/hup.2389, 29, 2, (105-108),

Joseph J. Palamar, Dimitra Kamboukos, An Examination of Sociodemographic Correlates of Ecstasy Use Among High School Seniors in the United States, Substance Use & Misuse, 10.3109/10826084.2014.926933, 49, 13, (1774-1783),

John JD Turner, Andrew C Parrott, Julia Goodwin, Derek G Moore, Sarah Fulton, Meeyoung O Min, Lynn T Singer, Psychiatric profiles of mothers who take Ecstasy/MDMA during pregnancy: Reduced depression 1 year after giving birth and quitting Ecstasy, Journal of Psychopharmacology, 10.1177/0269881113515061, 28, 1, (55-61),

Andrew C. Parrott, MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational ‘Ecstasy’ users, Neuroscience & Biobehavioral Reviews, 10.1016/j.neubiorev.2013.04.016, 37, 8, (1466-1484),